Eye Washing Downregulated Angiotensin-Converting Enzyme 2 in Conjunctival Tissue Samples from Smokers

Int J Mol Sci. 2023 Dec 15;24(24):17526. doi: 10.3390/ijms242417526.

Abstract

This study aimed to (1) determine whether the expression of angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 is increased in tobacco smokers, which potentially increases their susceptibility to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, and (2) assess whether eye rinsing can reduce susceptibility. This prospective study included 20 eyes of 10 smokers and 18 eyes of nine healthy non-smokers (control) for reverse-transcription polymerase chain reaction. This study also included 28 eyes of 14 smokers and 16 eyes of eight healthy non-smokers (control) for enzyme-linked immunosorbent assay. Tear and impression cytology samples were collected from the right eye of each patient. The left eye was then rinsed for 30 s, and after 5 min, the tear and impression cytology samples were collected in the same manner. The expression of the ACE2 gene was significantly higher in the conjunctiva of smokers (n = 17; median 3.07 copies/ng of total RNA) than in those of non-smokers (n = 17; median 1.92 copies/ng of total RNA, p = 0.003). Further, mRNA expression and protein levels of ACE2 were weakly correlated in smokers (r = 0.49). ACE2 protein levels in Schirmer's strip samples were significantly reduced from 5051 to 3202 pg/mL after eye washing (n = 10; p = 0.001). Ocular surface cells are susceptible to SARS-CoV-2 infection. Smoking may be a risk factor for SARS-CoV-2 infection, and eye rinsing may reduce the risk of infection.

Keywords: SARS-CoV-2 infection; angiotensin-converting enzyme 2 (ACE2); eye rinsing; smoking; transmembrane protease serine 2 (TMPRSS2).

MeSH terms

  • Angiotensin-Converting Enzyme 2* / genetics
  • Angiotensin-Converting Enzyme 2* / metabolism
  • COVID-19* / metabolism
  • COVID-19* / prevention & control
  • Conjunctiva / metabolism
  • Eye / metabolism
  • Humans
  • Prospective Studies
  • RNA / metabolism
  • SARS-CoV-2 / metabolism
  • Smokers

Substances

  • Angiotensin-Converting Enzyme 2
  • RNA

Grants and funding

This research was supported in part by grants from Tsurumi University (#6203) but did not receive any specific grants from funding agencies in the public, commercial, or not-for-profit sectors. An eye-wash solution (EYEBON; Kobayashi Pharmaceutical Co., Osaka, Japan) was provided to volunteers after the experiment.